Peptivir
Stage
Seed | AliveTotal Raised
$300KLast Raised
$300K | 12 yrs agoAbout Peptivir
PeptiVir is an early stage biopharmaceutical company focused on the development and commercialization of a conformationally-constrained, synthetic peptide-based vaccine platform for the prevention of viral diseases.
Missing: Peptivir's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Peptivir's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Peptivir Frequently Asked Questions (FAQ)
Where is Peptivir's headquarters?
Peptivir's headquarters is located at 12635 East Montview Blvd., Aurora.
What is Peptivir's latest funding round?
Peptivir's latest funding round is Seed.
How much did Peptivir raise?
Peptivir raised a total of $300K.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.